Clinical expansion of cord blood-derived t cells for use as donor lymphocyte infusion after cord blood transplantation

Journal of Immunotherapy

Volumn 33, Issue 1, 2010, Pages 96-105

  Okas, Mantas ^a,b   Gertow, Jens ^a,b   Uzunel, Mehmet ^a   Karlsson, Helen ^a   Westgren, Magnus ^a   Kärre, Klas ^b   Ringden, Olle ^a   Mattsson, Jonas ^a   Uhlin, Michael ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cell therapy; Cord blood; Hematopoietic stem cell transplantation; Immunotherapy; T cells

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL EXPANSION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE PRODUCTION; DONOR LYMPHOCYTE INFUSION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE CULTURE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

CELL CULTURE TECHNIQUES; CELL SEPARATION; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 74349115475     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3181b291a4     Document Type: Article

References (45)

1. Knudtzon S. In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood. 1974;43:357-361.
2. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hemato-poietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174-1178.
3. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157-166.
4. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276-2285.
5. Brunstein CG, Barker JN, Weisdorf DJ, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 2007;110:3064-3070.
6. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369:1947-1954.
7. Cornetta K, Laughlin M, Carter S, et al. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). Biol Blood Marrow Transplant. 2005;11:149-160. (Pubitemid 40186212)
8. Majhail NS, Brunstein CG, Wagner JE. Double umbilical cord blood transplantation. Curr Opin Immunol. 2006;18:571-575.
9. Dey BR, McAfee S, Colby C, et al. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2003;9:320-329.
10. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995;86:2041-2050.
11. Porter DL. The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and non-myeloablative allogeneic stem cell transplantation. J Hematother Stem Cell Res. 2001;10:465-480.
12. Bader P, Willasch A, Klingebiel T. Monitoring of post-transplant remission of childhood malignancies: is there a standard? Bone Marrow Transplant. 2008;42(suppl 2):S31-S34.
13. Parmar S, Robinson SN, Komanduri K, et al. Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity. Cytotherapy. 2006;8:149-157.
14. Levine BL, Bernstein WB, Aronson NE, et al. Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection. Nat Med. 2002;8:47-53.
15. Porter DL, Levine BL, Bunin N, et al. A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/ CD28 costimulation. Blood. 2006;107:1325-1331.
16. Introna M, Franceschetti M, Ciocca A, et al. Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation. Bone Marrow Transplant. 2006;38:621-627.
17. Robinson KL, Ayello J, Hughes R, et al. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation. Exp Hematol. 2002;30:245-251.
18. Tomizawa D, Aoki Y, Nagasawa M, et al. Novel adopted im-munotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome. Eur J Haematol. 2005;75:441-444.
19. Uhlin M, Masucci MG, Levitsky V. Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. Proc Natl Acad Sci USA. 2005;102:9264-9269.
20. Uhlin M, Masucci MG, Levitsky V. Pharmacological disintegration of lipid rafts decreases specific tetramer binding and disrupts the CD3 complex and CD8 heterodimer in human cytotoxic T lymphocytes. Scand J Immunol. 2003;57:99-106.
21. Hentschke P, Omazic B, Mattsson J, et al. T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Scand J Immunol. 2005;61:285-294. (Pubitemid 40462780)
22. Amrolia PJ, Muccioli-Casadei G, Yvon E, et al. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood. 2003;102:2292-2299.
23. Hartwig UF, Nonn M, Khan S, et al. Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes. Bone Marrow Transplant. 2006;37:297-305.
24. Caron G, Duluc D, Fremaux I, et al. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J Immunol. 2005;175:1551-1557.
25. Ladell K, Hellerstein MK, Cesar D, et al. Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression. J Immunol. 2008;180:7907-7918.
26. Gorski J, Yassai M, Zhu X, et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol. 1994;152:5109-5119.
27. van den Beemd R, Boor PP, van Lochem EG, et al. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry. 2000;40:336-345.
28. Chalmers IM, Janossy G, Contreras M, et al. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood. 1998;92:11-18.
29. Harris DT, Schumacher MJ, Locascio J, et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA. 1992;89: 10006-10010.
30. Kloosterboer FM, van Luxemburg-Heijs SA, Willemze R, et al. Similar potential to become activated and proliferate but differential kinetics and profiles of cytokine production of umbilical cord blood T cells and adult blood naive and memory T cells. Hum Immunol. 2006;67:874-883.
31. Rizzieri DA, Dev P, Long GD, et al. Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors. Bone Marrow Transplant. 2009;43:327-333.
32. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol. 1992;10:333-358.
33. Mazur MA, Davis CC, Szabolcs P. Ex vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/ CD28 costimulation. Biol Blood Marrow Transplant. 2008;14:1190-1196.
34. Azuma H, Yamada Y, Shibuya-Fujiwara N, et al. Functional evaluation of ex vivo expanded cord blood lymphocytes: possible use for adoptive cellular immunotherapy. Exp Hematol. 2002;30:346-351.
35. Zenzmaier C, Gesslbauer B, Grobuschek N, et al. Proteomic profiling of human stem cells derived from umbilical cord blood. Biochem Biophys Res Commun. 2005;328:968-972.
36. Marcolino I, Przybylski GK, Koschella M, et al. Frequent expression of the natural killer cell receptor KLRG1 in human cord blood T cells: correlation with replicative history. Eur J Immunol. 2004;34:2672-2680.
37. Fukui T, Katamura K, Abe N, et al. IL-7 induces proliferation, variable cytokine-producing ability and IL-2 responsiveness in naive CD4+ T-cells from human cord blood. Immunol Lett. 1997;59:21-28.
38. Sanchez M, Alfani E, Migliaccio AR, et al. Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2. Bone Marrow Transplant. 2003;31:713-723.
39. Desfrancois J, Derre L, Corvaisier M, et al. Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusions. Int J Cancer. 2009;125:374-380.
40. Parel Y, Aurrand-Lions M, Scheja A, et al. Presence of CD4+CD8+ double-positive T cells with very high inter-leukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum. 2007;56:3459-3467.
41. H2 paradigm. Immunol Res. 1996;15:50-73.
42. H17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood. 2009;113:1365-1374.
43. Oudshoorn M, van Walraven SM, Bakker JN, et al. Hematopoietic stem cell donor selection: the Europdonor experience. Hum Immunol. 2006;67:405-412.
44. Michallet M, Tanguy ML, Socie G, et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de moelle (SFGM). Br J Haematol. 2000;108:400-407.
45. Bernstein WB, Cox JH, Aronson NE, et al. Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected persons. Clin Immunol. 2004;111:262-274.